NR4A1 and malignant colon neoplasm: Limited data suggest that, like NR4A1, NR4A2 is also a pro-oncogenic factor in solid tumors, and in colon cancer, NR4A2 overexpression predicts an unfavorable prognosis and chemoresistance [28].